Despite the slump of large drugs, products of multinational pharmaceutical companies swept the market

Published: 2015-01-20 10:17:51

Updated: 2015-01-20 10:17:51

Despite the slump of large drugs, it is confirmed that most products positioning inthe toptier with prescription expenses are products of multinational pharmaceutical companies.

According to the Medipana News’s analysis result of the UBIST’s data regarding 50 products with the top prescription expenses in 2014, preparation expenses were KRW 2.1211 trillion that makes a 0.8% decrease compared t...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.